Annual EBIT
-$22.02 M
+$1.13 M+4.86%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual earnings before interest & taxes is -$22.02 million, with the most recent change of +$1.13 million (+4.86%) on December 31, 2023.
- During the last 3 years, EVAX annual EBIT has fallen by -$5.47 million (-33.07%).
- EVAX annual EBIT is now -295.15% below its all-time high of -$5.57 million, reached on December 31, 2018.
Performance
EVAX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.65 M
+$4.53 M+73.31%
September 1, 2024
Summary
- As of February 7, 2025, EVAX quarterly earnings before interest & taxes is -$1.65 million, with the most recent change of +$4.53 million (+73.31%) on September 1, 2024.
- Over the past year, EVAX quarterly EBIT has increased by +$4.04 million (+71.05%).
- EVAX quarterly EBIT is now -234.78% below its all-time high of $1.22 million, reached on March 31, 2024.
Performance
EVAX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$11.19 M
+$4.04 M+26.55%
September 1, 2024
Summary
- As of February 7, 2025, EVAX TTM earnings before interest & taxes is -$11.19 million, with the most recent change of +$4.04 million (+26.55%) on September 1, 2024.
- Over the past year, EVAX TTM EBIT has increased by +$13.46 million (+54.62%).
- EVAX TTM EBIT is now -198.93% below its all-time high of -$3.74 million, reached on December 31, 2019.
Performance
EVAX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EVAX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +4.9% | +71.0% | +54.6% |
3 y3 years | -33.1% | +78.7% | +54.4% |
5 y5 years | -295.1% | +65.3% | +32.4% |
EVAX EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +10.3% | -234.8% | +78.7% | at high | +57.4% |
5 y | 5-year | -103.9% | +10.3% | -234.8% | +78.7% | -198.9% | +57.4% |
alltime | all time | -295.1% | +10.3% | -234.8% | +78.7% | -198.9% | +57.4% |
Evaxion Biotech A/S EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.65 M(-73.3%) | -$11.19 M(-26.5%) |
Jun 2024 | - | -$6.17 M(-605.1%) | -$15.23 M(+3.3%) |
Mar 2024 | - | $1.22 M(-126.6%) | -$14.74 M(-33.2%) |
Dec 2023 | -$22.02 M(-4.9%) | -$4.59 M(-19.3%) | -$22.07 M(-10.4%) |
Sep 2023 | - | -$5.69 M(+0.1%) | -$24.65 M(+1.3%) |
Jun 2023 | - | -$5.69 M(-6.9%) | -$24.34 M(+4.1%) |
Mar 2023 | - | -$6.11 M(-14.7%) | -$23.37 M(+1.0%) |
Dec 2022 | -$23.14 M | -$7.17 M(+33.2%) | -$23.14 M(-2.4%) |
Sep 2022 | - | -$5.38 M(+14.0%) | -$23.71 M(-1.0%) |
Jun 2022 | - | -$4.72 M(-19.7%) | -$23.95 M(-8.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$5.88 M(-23.9%) | -$26.23 M(+6.8%) |
Dec 2021 | -$24.55 M(+48.4%) | -$7.73 M(+37.5%) | -$24.55 M(+13.8%) |
Sep 2021 | - | -$5.62 M(-19.6%) | -$21.57 M(+5.1%) |
Jun 2021 | - | -$6.99 M(+66.4%) | -$20.53 M(+17.5%) |
Mar 2021 | - | -$4.20 M(-11.5%) | -$17.47 M(+5.6%) |
Dec 2020 | -$16.55 M(+53.2%) | -$4.75 M(+3.6%) | -$16.55 M(+6.5%) |
Sep 2020 | - | -$4.58 M(+16.5%) | -$15.54 M(+41.9%) |
Jun 2020 | - | -$3.94 M(+20.2%) | -$10.95 M(+56.1%) |
Mar 2020 | - | -$3.27 M(-12.5%) | -$7.02 M(+87.5%) |
Dec 2019 | -$10.80 M(+93.8%) | -$3.74 M | -$3.74 M |
Dec 2018 | -$5.57 M | - | - |
FAQ
- What is Evaxion Biotech A/S annual earnings before interest & taxes?
- What is the all time high annual EBIT for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual EBIT year-on-year change?
- What is Evaxion Biotech A/S quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S quarterly EBIT year-on-year change?
- What is Evaxion Biotech A/S TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S TTM EBIT year-on-year change?
What is Evaxion Biotech A/S annual earnings before interest & taxes?
The current annual EBIT of EVAX is -$22.02 M
What is the all time high annual EBIT for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual earnings before interest & taxes is -$5.57 M
What is Evaxion Biotech A/S annual EBIT year-on-year change?
Over the past year, EVAX annual earnings before interest & taxes has changed by +$1.13 M (+4.86%)
What is Evaxion Biotech A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of EVAX is -$1.65 M
What is the all time high quarterly EBIT for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly earnings before interest & taxes is $1.22 M
What is Evaxion Biotech A/S quarterly EBIT year-on-year change?
Over the past year, EVAX quarterly earnings before interest & taxes has changed by +$4.04 M (+71.05%)
What is Evaxion Biotech A/S TTM earnings before interest & taxes?
The current TTM EBIT of EVAX is -$11.19 M
What is the all time high TTM EBIT for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high TTM earnings before interest & taxes is -$3.74 M
What is Evaxion Biotech A/S TTM EBIT year-on-year change?
Over the past year, EVAX TTM earnings before interest & taxes has changed by +$13.46 M (+54.62%)